Diaceutics (DIUXF) Stock Statistics & Valuation Metrics

Diaceutics has a market cap or net worth of $162.44M. The enterprise value is $114.83M.

Diaceutics has 84,922,280 shares outstanding. The number of shares has decreased by -2.65% in one year.

Diaceutics’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is -0.16%.

The current PE Ratio of Diaceutics is 1235.3. Diaceutics’s PEG ratio is -10.54.

In the last 12 months, Diaceutics had revenue of 38.44M and earned 97.00K in profits. Earnings per share was <0.01.

In the last 12 months, operating cash flow was 1.30M and capital expenditures -71.00K, giving a free cash flow of 1.23M billion.

Diaceutics pays an annual dividend of ―, resulting in a dividend yield of ―

Diaceutics upcoming earnings date is Sep 29, 2026, Before Open (Confirmed).

Diaceutics as a current ratio of 3.43, with Debt / Equity ratio of 2.85%

In the past 12 months, Diaceutics has paid 205.00K in taxes.

Diaceutics EV to EBITDA ratio is 18.23, with an EV/FCF ratio of 71.63.

Diaceutics has $7.34M in cash and marketable securities with $1.15M in debt, giving a net cash position of $6.19M billion.

Gross margin is 73.80%, with operating margin of -0.55%, and net profit margin of 0.25%.

The average price target for Diaceutics is $2.90, which is 11.43% higher than the current price. The consensus rating is Moderate Buy